SMTL ID : 8tx0.1 (1 other biounit)

IRAK4 in complex with compound

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

monomer

Ligands

1 x VEU: ~{N}-(1-cyclopropyl-2-oxidanylidene-pyridin-3-yl)-2-(1-methyl-2-oxabicyclo[2.1.1]hexan-4-yl)-7-propan-2-yloxy-imidazo[1,2-a]pyrimidine-6-carboxamide

VEU.1: 17 residues within 4Å: Chain A: M.39, G.40, V.47, A.58, Y.109, V.110, Y.111, M.112, P.113, G.115, S.116, R.120, D.125, T.127, L.165, S.175, D.176 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:V.47, A:V.47, A:A.58, A:Y.109, A:Y.109, A:D.125, A:T.127, A:L.165 Hydrogen bonds: A:M.112 Water bridges: A:S.116, A:R.120

2 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 3 residues within 4Å: Chain A: N.54, T.55, T.56 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:T.56 EDO.3: 7 residues within 4Å: Chain A: R.157, T.192, I.195, V.196, A.206, G.209, E.210 4 PLIP interactions: 4 interactions with chain A Hydrogen bonds: A:R.157, A:V.196, A:G.209, A:G.209

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Pfaffenbach, M. et al., Discovery of BIO-8169─A Highly Potent, Selective, and Brain-Penetrant IRAK4 Inhibitor for the Treatment of Neuroinflammation. J.Med.Chem. (2024)

Release Date

2024-06-26

Peptides

Interleukin-1 receptor-associated kinase 4: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Interleukin-1 receptor-associated kinase 4

Related Entries With Identical Sequence